01:32Baby thrives after receiving personalized gene-editing therapy
From the creator
One week after he was born, KJ Muldoon was diagnosed with what doctors call a CPS-1 deficiency, essentially meaning he was missing a critical liver enzyme. With doctors believing they only had six months to come up with a solution, KJ became the first patient in the world to receive a custom gene-editing drug in February — and he is thriving after three doses of the therapy. NBC’s Erin McLaughlin reports for TODAY on how this could be a blueprint for future treatment. » Subscribe to TODAY: https://www.youtube.com/@TODAY About: TODAY brings you the latest headlines and expert tips on money, health and parenting. We wake up every morning to give you and your family all you need to start your day. If it matters to you, it matters to us. We are in the people business. Subscribe to our channel for exclusive TODAY archival footage & our original web series. Connect with TODAY Online! Visit TODAY's Website: https://www.today.com/ Find TODAY on Facebook: https://www.facebook.com/today Follow TODAY on Twitter: https://twitter.com/TODAYshow Follow TODAY on Instagram: https://www.instagram.com/todayshow/ » Stream TODAY All Day: https://www.today.com/allday About: TODAY All Day is a 24/7 streaming channel bringing you the top stories in news and pop culture, celebrity interviews, cooking, and more. All in one place. #genetherapy #health #science
Published 2025-05-16 · Watch on YouTube ↗
Availability and playback restrictions are controlled by the original channel.
Keep exploring News
01:32
01:57Al Jazeera explains: The US-China AI race is entering a new phase | AJ #shorts
Al Jazeera English
02:11
01:51
02:30Cricket Australia backs Cummins as Khawaja, Warner rested from commentary | ABC NEWS
ABC News (Australia)
02:05
02:06